Loading the section…

NTRB: financial statements from SEC — TradeAlmanac

NTRB

Nutriband Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/01/2026	31/01/2025
Revenue	2M	2M
Cost of revenue	1M	1M
Research and development	2M	3M
Selling, general and administrative	7M	4M
Operating expenses	10M	12M
Operating income	−8M	−10M
Pre-tax income	−8M	−10M
Net income	−8M	−10M
Earnings per share	−2.58	−0.99
Earnings per share, diluted	−2.58	−0.99
Weighted average shares	12M	11M
Weighted average shares, diluted	12M	11M

Balance sheet

Metric	30/04/2026	31/01/2026	31/10/2025	31/07/2025	30/04/2025	31/01/2025	31/10/2024	31/08/2024
Cash and equivalents	4M	5M	5M	7M	3M	4M	6M	—
Receivables	2,632	118,404	147,562

Cash flow

Metric	31/01/2026	31/01/2025
Operating cash flow	−5M	−5M
Depreciation and amortisation	193,797	285,054
Share-based compensation	3M	1M
Capital expenditure	5,324	92,043
Investing cash flow	−5,324	−92,043
Financing cash flow	5M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator